Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 WatersPerkinElmerAvantorBio-Rad Laboratories
SymbolNYSE:WATNYSE:PKINYSE:AVTRNYSE:BIO
Price Information
Current Price$188.63$101.47$18.21$477.66
52 Week RangeSellHoldBuyBuy
Beat the Market™ Rank
Overall Score1.21.61.51.5
Analysis Score1.72.22.41.6
Community Score2.12.52.82.4
Dividend Score0.01.70.00.0
Ownership Score1.01.01.01.0
Earnings & Valuation Score1.30.61.32.5
Analyst Ratings
Consensus RecommendationSellHoldBuyBuy
Consensus Price Target$176.38$83.73$18.90$470.00
% Upside from Price Target-6.50% downside-17.48% downside3.79% upside-1.60% downside
Trade Information
Market Cap$11.68 billion$11.48 billion$10.74 billion$14.17 billion
Beta0.941.372.011.08
Average Volume600,293772,7444,140,362418,721
Sales & Book Value
Annual Revenue$2.41 billion$2.88 billion$6.04 billion$2.31 billion
Price / Sales4.853.921.736.13
Cashflow$11.36 per share$6.18 per shareN/A$7.12 per share
Price / Cash16.6116.43N/A67.13
Book Value($3.36) per share$25.33 per shareN/A$192.32 per share
Price / Book-56.144.012.48
Profitability
Net Income$592.20 million$227.56 millionN/A$1.76 billion
EPS$8.99$4.10$0.58$7.06
Trailing P/E Ratio23.2050.23N/A9.15
Forward P/E Ratio21.2222.4021.4251.92
P/E Growth$5.75$3.42$1.45N/A
Net Margins22.77%7.82%N/A67.81%
Return on Equity (ROE)1,937.83%16.52%N/A3.95%
Return on Assets (ROA)21.46%7.03%N/A2.84%
Dividend
Annual PayoutN/A$0.28N/AN/A
Dividend YieldN/A0.28%N/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/A
Payout RatioN/A6.83%N/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.79%N/A0.03%
Current Ratio2.41%1.84%N/A2.40%
Quick Ratio1.79%1.30%N/A1.76%
Ownership Information
Institutional Ownership Percentage94.95%93.46%78.88%63.08%
Insider Ownership Percentage1.50%0.62%1.90%27.50%
Miscellaneous
Employees7,50013,00012,0008,120
Shares Outstanding61.91 million111.39 million574.89 million29.65 million
Next Earnings Date8/4/2020 (Estimated)8/3/2020 (Estimated)7/29/2020 (Confirmed)8/6/2020 (Estimated)
OptionableOptionableOptionableNot OptionableOptionable

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.